Platelet count abnormal and Weight decreased

Summary:

Weight decreased is found among people with Platelet count abnormal, especially for people who are female, 60+ old.

The study analyzes which people have Weight decreased with Platelet count abnormal. It is created by eHealthMe based on reports of 13 people who have Platelet count abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Platelet count abnormal?

Platelet count abnormal is found to be associated with 542 drugs and 589 conditions by eHealthMe. Check the latest studies of Platelet count abnormal.

What is Weight decreased?

Weight decreased is found to be associated with 3,393 drugs and 4,744 conditions by eHealthMe. Check the latest studies of Weight decreased.



On Jul, 15, 2026

13 people who have Platelet Count Abnormal and Weight Decreased are studied.

Would you have Weight decreased when you have Platelet count abnormal?

Gender of people who have Platelet Count Abnormal and experienced Weight Decreased *:

  • female: 63.64 %
  • male: 36.36 %

Age of people who have Platelet Count Abnormal and experienced Weight Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 22.22 %
  • 60+: 77.78 %

Common co-existing conditions for these people *:

  1. Thrombocytosis: 6 people, 46.15%
  2. Urinary Tract Disorder: 3 people, 23.08%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 23.08%
  4. Pain: 3 people, 23.08%
  5. Neuralgia (pain in one or more nerves): 3 people, 23.08%
  6. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
  8. Hypersensitivity: 3 people, 23.08%
  9. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 3 people, 23.08%
  10. Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 7.69%

Common drugs taken by these people *:

  1. Allopurinol: 7 people, 53.85%
  2. Hydroxyurea: 7 people, 53.85%
  3. Azathioprine: 6 people, 46.15%
  4. Mesalamine: 6 people, 46.15%
  5. Methylprednisolone: 6 people, 46.15%
  6. Prednisone: 6 people, 46.15%
  7. Magnesium: 4 people, 30.77%
  8. Pantoprazole: 4 people, 30.77%
  9. Zyrtec: 3 people, 23.08%
  10. Rapaflo: 3 people, 23.08%

Common symptoms for these people *:

  1. Weakness: 10 people, 76.92%
  2. Diarrhea: 7 people, 53.85%
  3. Splenomegaly (enlargement of spleen): 6 people, 46.15%
  4. Anaemia (lack of blood): 6 people, 46.15%
  5. Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 46.15%
  6. Platelet Count Increased: 6 people, 46.15%
  7. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 46.15%
  8. Abdominal Pain: 5 people, 38.46%
  9. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 38.46%
  10. Bone Marrow Reticulin Fibrosis (thickening and scarring of bone marrow reticulin): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Weight decreased:

All the conditions that are associated with Weight decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decreased and Platelet count abnormal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: